Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?

Cancer metastasis reviews - 1 Mar 2014

Raymond E, García-Carbonero R, Wiedenmann B, Grande E, Pavel M

Abstract excerpt

Over the last few years, there have been important advances in the understanding of the molecular biology of neuroendocrine tumors (NETs) that have already translated into relevant advances in the clinic. Several studies have extensively assessed the mutational profile of NETs, and have shown the key roles that angiogenesis and the PI3K-AKT-mTOR pathway play in the pathogenesis of these tumors. Recent data has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Forecasting
Share to Intestinal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Share to Signal Transduction

Share to Stomach Neoplasms

Source

Identifiers

PMID: 24375390
DOI: 10.1007/s10555-013-9467-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?PMID 24375390Read ↗

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).Semantic proximity Read ↗

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the FutureSemantic proximity Read ↗

Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets.Semantic proximity Read ↗

Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches.Semantic proximity Read ↗

GEP- NETS UPDATE: Genetics of neuroendocrine tumorsSemantic proximity Read ↗

The evolving landscape of neuroendocrine tumors.Semantic proximity Read ↗

Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.Semantic proximity Read ↗

Concept of neuroendocrine neoplasms of all organs with a focus on grading, subtyping.Semantic proximity Read ↗

Pharmacogenetics in neuroendocrine tumors of the pancreas.Semantic proximity Read ↗

Current understanding of the molecular biology of pancreatic neuroendocrine tumors.Semantic proximity Read ↗

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.Semantic proximity Read ↗

Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.